A detailed history of Met Life Investment Management, LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 19,412 shares of MORF stock, worth $661,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,412
Holding current value
$661,366
% of portfolio
0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$26.64 - $40.31 $517,135 - $782,497
19,412 New
19,412 $683,000
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $25,097 - $38,998
1,258 Added 6.93%
19,412 $560,000
Q3 2023

May 09, 2024

BUY
$21.33 - $59.42 $98,309 - $273,866
4,609 Added 34.03%
18,154 $415,000
Q3 2023

Apr 29, 2024

BUY
$21.33 - $59.42 $44,920 - $125,138
2,106 Added 13.12%
18,154 $415,000
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $44,920 - $125,138
2,106 Added 13.12%
18,154 $415,000
Q2 2023

Apr 29, 2024

BUY
$34.33 - $62.11 $550,927 - $996,741
16,048 New
16,048 $920,000
Q2 2023

Aug 10, 2023

BUY
$34.33 - $62.11 $85,927 - $155,461
2,503 Added 18.48%
16,048 $920,000
Q1 2023

May 09, 2024

BUY
$26.01 - $48.69 $352,305 - $659,506
13,545 New
13,545 $510 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $9,363 - $17,528
360 Added 2.73%
13,545 $509,000
Q4 2022

May 10, 2024

SELL
$24.14 - $30.37 $38,551 - $48,500
-1,597 Reduced 10.8%
13,185 $352,000
Q4 2022

Jun 14, 2023

SELL
$24.14 - $30.37 $8,690 - $10,933
-360 Reduced 2.66%
13,185 $352,000
Q4 2022

Mar 22, 2023

SELL
$24.14 - $30.37 $38,551 - $48,500
-1,597 Reduced 10.8%
13,185 $352,000
Q4 2022

Feb 15, 2023

SELL
$24.14 - $30.37 $38,551 - $48,500
-1,597 Reduced 10.8%
13,185 $352,000
Q3 2022

May 10, 2024

BUY
$22.23 - $33.37 $58,109 - $87,229
2,614 Added 21.48%
14,782 $418,000
Q3 2022

Jun 14, 2023

BUY
$22.23 - $33.37 $27,498 - $41,278
1,237 Added 9.13%
14,782 $418,000
Q3 2022

Mar 22, 2023

BUY
$22.23 - $33.37 $58,109 - $87,229
2,614 Added 21.48%
14,782 $418,000
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $58,109 - $87,229
2,614 Added 21.48%
14,782 $418,000
Q2 2022

Jun 20, 2023

SELL
$19.74 - $43.01 $27,181 - $59,224
-1,377 Reduced 10.17%
12,168 $264,000
Q1 2022

May 10, 2024

BUY
$36.25 - $52.02 $441,090 - $632,979
12,168 New
12,168 $488,000
Q1 2022

Jun 20, 2023

SELL
$36.25 - $52.02 $49,916 - $71,631
-1,377 Reduced 10.17%
12,168 $488,000
Q1 2022

Mar 22, 2023

BUY
$36.25 - $52.02 $162,798 - $233,621
4,491 Added 58.5%
12,168 $488,000
Q1 2022

May 12, 2022

BUY
$36.25 - $52.02 $162,798 - $233,621
4,491 Added 58.5%
12,168 $489,000
Q4 2021

Jun 21, 2023

SELL
$43.27 - $65.72 $253,908 - $385,644
-5,868 Reduced 43.32%
7,677 $363,000
Q3 2021

Jun 21, 2023

SELL
$53.61 - $67.5 $314,583 - $396,090
-5,868 Reduced 43.32%
7,677 $434,000
Q2 2021

May 17, 2024

BUY
$45.13 - $64.99 $47,251 - $68,044
1,047 Added 15.79%
7,677 $440,000
Q2 2021

Jun 21, 2023

SELL
$45.13 - $64.99 $264,822 - $381,361
-5,868 Reduced 43.32%
7,677 $440,000
Q2 2021

Mar 22, 2023

BUY
$45.13 - $64.99 $47,251 - $68,044
1,047 Added 15.79%
7,677 $440,000
Q2 2021

Aug 16, 2021

BUY
$45.13 - $64.99 $47,251 - $68,044
1,047 Added 15.79%
7,677 $441,000
Q1 2021

May 17, 2024

SELL
$29.77 - $84.85 $380,520 - $1.08 Million
-12,782 Reduced 65.85%
6,630 $419,000
Q1 2021

Jun 26, 2023

SELL
$29.77 - $84.85 $205,859 - $586,737
-6,915 Reduced 51.05%
6,630 $420 Million
Q4 2020

Jun 22, 2023

SELL
$25.66 - $34.55 $177,438 - $238,913
-6,915 Reduced 51.05%
6,630 $222,000
Q3 2020

Jun 26, 2023

SELL
$22.51 - $30.11 $155,656 - $208,210
-6,915 Reduced 51.05%
6,630 $181,000
Q2 2020

May 24, 2024

SELL
$12.65 - $29.57 $161,692 - $377,963
-12,782 Reduced 65.85%
6,630 $179 Million
Q2 2020

Jun 26, 2023

SELL
$12.65 - $29.57 $87,474 - $204,476
-6,915 Reduced 51.05%
6,630 $179,000
Q2 2020

Mar 22, 2023

SELL
$12.65 - $29.57 $82,920 - $193,831
-6,555 Reduced 49.72%
6,630 $179,000
Q2 2020

Aug 14, 2020

BUY
$12.65 - $29.57 $83,869 - $196,049
6,630 New
6,630 $179,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.